NMC
PHAT icon

NEA Management Company’s Phathom Pharmaceuticals PHAT Stock Holding History

NEA Management Company’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.8M Hold
1,960,169
– – 1.24% 13
2025
Q4 		$32.5M Hold
1,960,169
– – 1.66% 14
2025
Q3 		$23.1M Hold
1,960,169
– – 1.27% 16
2025
Q2 		$18.8M Hold
1,960,169
– – 1.42% 16
2025
Q1 		$12.3M Hold
1,960,169
– – 0.95% 20
2024
Q4 		$15.9M Hold
1,960,169
– – 0.9% 19
2024
Q3 		$35.4M Hold
1,960,169
– – 1.93% 14
2024
Q2 		$20.2M Hold
1,960,169
– – 1.52% 17
2024
Q1 		$20.8M Hold
1,960,169
– – 1.29% 18
2023
Q4 		$17.9M Buy
1,960,169
+683,574
+54% +$5.89M 1.19% 17
2023
Q3 		$12.2M Hold
1,276,595
– – 0.95% 25
2023
Q2 		$18.3M Buy
+1,276,595
New +$14.7M 1.4% 21

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return

NEA Management Company's PHAT Position: Q1 2026 in Review

NEA Management Company held its Phathom Pharmaceuticals (PHAT) position steady in Q1 2026 at 1,960,169 shares worth $21.8M. The position accounts for 1.24% of the portfolio, ranked #13.

NEA Management Company first reported a position in PHAT in Q2 2023 and has held it in 12 quarters since. The position peaked at $35.4M in Q3 2024. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

  • NEA Management Company held 1,960,169 shares of Phathom Pharmaceuticals worth $21.8M as of Q1 2026.
  • NEA Management Company left its Phathom Pharmaceuticals share count unchanged in Q1 2026.
  • Phathom Pharmaceuticals made up 1.24% of NEA Management Company's portfolio in Q1 2026, its #13 holding.
  • NEA Management Company first reported a position in Phathom Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • NEA Management Company's Phathom Pharmaceuticals position peaked at $35.4M in Q3 2024.
  • 174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on NEA Management Company's 13F filing for Q1 2026, filed 15 May 2026.